Related Experiment Video
Updated: Nov 10, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Treatment Protocol for COVID-19 Based on T2R Phenotype.
Mohamed A Taha1,2, Christian A Hall1,3, Colin J Shortess1
1Rhinology and Skull Base Research Group, Baton Rouge General Medical Center, 8585 Picardy Ave., Suite 210, Baton Rouge, LA 70809, USA.
Tailoring COVID-19 treatments to bitter taste receptor 38 (T2R38) phenotypes significantly impacts symptom duration. This personalized approach shows promise for improving patient outcomes in the ongoing pandemic.
Area of Science:
- Immunology
- Genetics
- Pharmacology
Background:
- COVID-19 pandemic necessitates effective treatments.
- Bitter taste receptor 38 (T2R38) phenotypes linked to COVID-19 severity.
- Varied treatment responses observed globally.
Purpose of the Study:
- Assess T2R38 phenotypes' response to targeted COVID-19 treatment.
- Investigate if personalized medicine improves outcomes.
Main Methods:
- Categorized 747 COVID-19 patients into supertasters, tasters, and nontasters based on T2R38 expression.
- Administered phenotype-specific treatment protocols (dexamethasone, azithromycin, hydroxychloroquine).
- Monitored symptom duration and hospitalization rates prospectively.
Main Results:
- Average symptom duration: 5 days (supertasters), 8.1 days (tasters), 16.2 days (nontasters).
- Only 3 nontasters required hospitalization.
- Significant correlation (p < 0.05) between T2R38 phenotype and treatment outcome.
Conclusions:
- Targeted COVID-19 treatment based on T2R38 phenotype is effective.
- Personalized medicine approach may explain inconsistent study results.
- Further research on T2R38 phenotype categorization is warranted.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

